Jana Portnow
- Genetics top 1%
- Glioma Diagnosis and Treatment 31
- Virus-based gene therapy research 4
- Oncology top 2%
- CAR-T cell therapy research 12
- Cancer Treatment and Pharmacology 5
- Peptidase Inhibition and Analysis 4
- Developmental Neuroscience top 5%
- Immunology top 5%
- Genetics top 5%
- Glioma Diagnosis and Treatment 31
- Virus-based gene therapy research 4
-
- Brain Metastases and Treatment 12
-
- Cancer Research and Treatments 10
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- Behnam BadieChristine E. BrownTimothy W. SynoldMassimo D’ApuzzoStephen J. FormanJulie R. OstbergMichael E. BarishSuzette Blanchard
- Journals
- Journal of Clinical Oncology (13 papers)Cancer Research (3 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Jana Portnow
57 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Genetics 713
- Oncology 1.2k
- Developmental Neuroscience 96
- Immunology 432
- Genetics 371
Countries citing papers authored by Jana Portnow
This map shows the geographic impact of Jana Portnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Portnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Portnow more than expected).
Fields of papers citing papers by Jana Portnow
This network shows the impact of papers produced by Jana Portnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Portnow. The network helps show where Jana Portnow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jana Portnow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 15 | |
| 9 | 2019 | 28 | |
| 10 | 2018 | 5 | |
| 11 | 2017 | 249 | |
| 12 | 2016 | 127 | |
| 13 | Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastomabreakdown → | 2015 | 592 |
| 14 | 2015 | 3 | |
| 15 | 2014 | 2 | |
| 16 | 2014 | 17 | |
| 17 | 2011 | 10 | |
| 18 | 2010 | 26 | |
| 19 | 2008 | 37 | |
| 20 | A randomized phase II neoadjuvant trial in patients with stages II-III and inflammatory breast cancer. | 2007 | 2 |
About Jana Portnow
Jana Portnow is a scholar working on Genetics, Biotechnology and Oncology, having authored 60 papers that have together received 2.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (31 papers), Brain Metastases and Treatment (12 papers), CAR-T cell therapy research (12 papers), Cancer Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers), Virus-based gene therapy research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Genetics (713 citations), Oncology (1.2k citations) and Developmental Neuroscience (96 citations). Jana Portnow has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Behnam Badie, Christine E. Brown, Timothy W. Synold, Massimo D’Apuzzo, Stephen J. Forman, Julie R. Ostberg, Michael E. Barish, Suzette Blanchard, Mike Y. Chen and Renate Starr. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.